Literature DB >> 10919737

Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: case-control studies of Japanese Brazilians and non-Japanese Brazilians.

I N Nishimoto1, T Hanaoka, H Sugimura, K Nagura, M Ihara, X J Li, T Arai, G S Hamada, L P Kowalski, S Tsugane.   

Abstract

Cytochrome P450 2E1 (Cyp2E1) is involved in the metabolic oxidation of carcinogenic nitroso compounds, including N-nitrosoamines. There is an RsaI polymorphism in the transcriptional regulatory region of this gene, and in vitro evidence suggests that the variant type of this polymorphic site has higher transcriptional activity but less chlorzoxazone-metabolizing activity. Interindividual differences in the metabolic capacity of Cyp2E1 are assumed to be associated with cancer susceptibility, but the results of the previous studies on the relation between Cyp2E1 RsaI polymorphism and cancer susceptibility have been inconsistent. Two case-control studies of gastric cancer in Japanese Brazilians (96 cases, 192 controls) and Brazilians not of Japanese ancestry (non-Japanese Brazilians; 236 cases, 236 controls) in São Paulo were designed to clarify the role of the Cyp2E1 RsaI genotype in susceptibility to gastric cancer after considering multifactorial environmental influences. The subjects with variant RsaI genotypes amounted to 47% (28 of 59) and 48% (64 of 133), respectively, of the Japanese cases and controls, and 6% (11 of 187) and 10% (19 of 192), respectively, of the non-Japanese cases and controls. As expected, a difference in the distributions of the two groups was observed. The odds ratio of the RsaI variant genotype of Cyp2E1 was 0.46 (95% confidence interval, 0.21-1.04) in the non-Japanese Brazilian population and 0.98 (95% confidence interval, 0.50-1.90) in the Japanese Brazilian population after adjusting for sex, age, tobacco use, and meat consumption. Additional adjustment for potential confounding factors did not change the odds ratio substantially. No significant interactions were observed between the polymorphism and environmental factors. In regard to the histological type of gastric cancer, the variant genotype was significantly more prevalent than the common genotype in Japanese subjects with diffuse type gastric cancer. Our study suggests that the Cyp2E1 RsaI polymorphism is associated with a reduced risk of gastric cancer, although how the assumed increase in Cyp2E1 expression produced by this polymorphism is related to a reduced risk of cancer remains unclear. The observations in this study are consistent with the recent observations of esophageal cancer in endemic areas of China.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919737

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature.

Authors:  Chun-Xia Yang; Keitaro Matsuo; Zhi-Ming Wang; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

2.  Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China.

Authors:  Xiao-Mei Lu; Yue-Ming Zhang; Ren-Yong Lin; Gul Arzi; Xing Wang; Ya-Lou Zhang; Yan Zhang; Yan Wang; Hao Wen
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

3.  Effects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer.

Authors:  Hong-Mei Nan; Young-Jin Song; Hyo-Yung Yun; Joo-Seung Park; Heon Kim
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 4.  Gene-diet interactions in gastric cancer risk: a systematic review.

Authors:  Jeongseon Kim; Young Ae Cho; Wook Jin Choi; Seung Hwa Jeong
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

5.  Use of duplex PCR-CTPP methods for CYP2E1RsaI/IL-2 T-330G and IL-1B C-31T/TNF-A T-1031C polymorphisms.

Authors:  Yoshiko Atsuta; Haruya Kawase; Nobuyuki Hamajima; Kazuko Nishio; Yoshimitsu Niwa; Daisuke Tanaka; Kazuhito Yamamoto; Akiko Tamakoshi
Journal:  Mol Diagn       Date:  2005

Review 6.  Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries.

Authors:  Miguel Angel Chiurillo
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

7.  Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population.

Authors:  Jiang-Mei Qin; Lei Yang; Bo Chen; Xiu-Mei Wang; Feng Li; Pei-Hua Liao; Lin He
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  GSTT1, GSTM1 and CYP2E1 genetic polymorphisms in gastric cancer and chronic gastritis in a Brazilian population.

Authors:  Jucimara Colombo; Andréa Regina Baptista Rossit; Alaor Caetano; Aldenis Albaneze Borim; Durval Wornrath; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

9.  Molecular epidemiology of gastric cancer: current status and future prospects.

Authors:  Zhibin Hu; Jaffer A Ajani; Qingyi Wei
Journal:  Gastrointest Cancer Res       Date:  2007-01

10.  CYP2E1 Rsa I polymorphism impacts on risk of colorectal cancer association with smoking and alcohol drinking.

Authors:  Chang-Ming Gao; Toshiro Takezaki; Jian-Zhong Wu; Min-Bin Chen; Yan-Ting Liu; Jian-Hua Ding; Haruhiko Sugimura; Jia Cao; Nobuyuki Hamajima; Kazuo Tajima
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.